Tempus ECG-AF vs Vivid E80
AI Verdict
Choose Tempus ECG-AF if…
Choose Tempus ECG-AF if your primary goal is to proactively identify older patients (65+) at increased risk of developing new-onset atrial fibrillation within the next year, utilizing existing 12-lead ECG data. This tool is ideal for integrating into routine geriatric or internal medicine screenings to support earlier intervention and follow-up for AF risk management.
View Tempus ECG-AF →Choose Vivid E80 if…
Choose GE HealthCare's Vivid E80 if you require an advanced, AI-powered ultrasound system for real-time, comprehensive cardiovascular imaging and precise diagnostic measurements. This system is best suited for cardiologists and radiologists performing detailed cardiac assessments, aiming to enhance diagnostic accuracy and workflow efficiency during live ultrasound examinations.
View Vivid E80 →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Tempus ECG-AF | Vivid E80 |
|---|---|---|
| Pricing | Contact vendor | Quote-based |
| Deployment | Software solution, integrated into healthcare facility systems with advanced cardiology algorithms. | On-premise (medical device) |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Yes AI-estimated | Yes AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Tempus ECG-AFTempus ECG-AF (Tool A) is a software solution designed for integration into existing healthcare facility systems and is compatible with FDA-authorized 12-lead ECGs from major manufacturers. This approach likely offers a lower barrier to adoption by augmenting current workflows rather than requiring the operation of new dedicated hardware, making it highly usable. While GE HealthCare Vivid E80 (Tool B) enhances the usability of its ultrasound system with integrated AI features, it still involves operating a specialized medical device.
Clinical Value
Tempus ECG-AFTempus ECG-AF (Tool A) provides a unique predictive capability by identifying patients at increased risk of developing atrial fibrillation within the next 12 months from standard ECGs, enabling proactive management and earlier intervention for a serious condition. GE HealthCare Vivid E80 (Tool B) enhances diagnostic precision and workflow efficiency for a broader range of cardiovascular assessments through integrated AI features. However, Tool A's predictive nature for early disease risk detection offers a distinct and potentially higher clinical impact.
Pricing & Value
Tempus ECG-AFTempus ECG-AF (Tool A) offers clear transparency regarding CMS reimbursement, including specific CPT codes (0764T and 0765T) and a Medicare rate of $128.90, effective January 1, 2025. This provides a clear path to cost recovery for healthcare providers. In contrast, GE HealthCare Vivid E80 (Tool B) is quote-based with no public pricing details, making its value assessment more challenging without direct engagement.
Enterprise Readiness
TieBoth Tempus ECG-AF (Tool A) and GE HealthCare Vivid E80 (Tool B) are FDA-cleared, HIPAA compliant, and offer Business Associate Agreements (BAAs), demonstrating adherence to critical regulatory and security standards for healthcare enterprises. Their respective deployment modelsu2014software integration for Tool A and on-premise medical device for Tool Bu2014are standard for their product types, indicating both are equally prepared for enterprise adoption.
Innovation
Tempus ECG-AFTempus ECG-AF (Tool A) represents a significant innovation by applying AI to standard 12-lead ECGs to predict the future risk of atrial fibrillation, moving beyond traditional diagnostic interpretation. While GE HealthCare Vivid E80 (Tool B) offers advanced AI features that automate and enhance existing ultrasound measurements and views, Tool A's predictive approach to disease risk detection is a more novel application of AI in clinical practice.
Support & Docs
Vivid E80GE HealthCare (Tool B) demonstrates a more robust and comprehensive support and documentation ecosystem, offering 'Expert Live Support' with remote monitoring, software updates, and direct access to technical and clinical experts. They also provide a 'STAR app' for education, extensive online documentation portals, and an applications hotline. Tempus (Tool A) provides standard contact methods for support and a resource center, but lacks the detailed, multi-faceted support infrastructure described by GE HealthCare.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Tempus ECG-AF | Vivid E80 |
|---|---|---|
| Name | Tempus ECG-AF | Vivid E80 |
| Company | Tempus AI, Inc. | GE HealthCare |
| Description | FDA-cleared AI-based algorithm that analyzes 12-lead ECG recordings to identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter (AF) within the next 12 months, supporting earlier identification and follow-up. | Advanced AI-powered ultrasound systems for cardiovascular imaging, enhancing diagnostic precision and workflow efficiency through integrated AI features. |
| Primary Category | Cardiology AI | Cardiology AI, Radiology & Imaging AI |
| Key Features (Examples) | AI-based algorithm for 12-lead ECG analysis; Detects signs associated with new onset Atrial Fibrillation (AF) within 12 months; Intended for patients 65 years or older without pre-existing AF, pacemakers, ICDs, or recent cardiac surgery. | AI Auto Measure 2D (for left ventricle dimensions); Easy AutoEF (AI-based ejection fraction measurement); AI FlexiViews LAA (Left Atrial Appendage localization). |
Videos
Demos, reviews, and walkthroughs featuring Tempus ECG-AF and Vivid E80.